Difficulty: Medium
Average Score: 79%
Practice
The preferred drug for status epilepticus is
Correct answer
A
Rationale
In the treatment of status epilepticus, the preferred drug is intravenous diazepam (Option A) for several reasons. Diazepam acts quickly to terminate seizures by enhancing the inhibitory action of gamma-aminobutyric acid (GABA) in the brain. Its rapid onset of action and effectiveness make it the initial drug of choice in managing status epilepticus.
Intravenous phenytoin sodium (Option B) is not the preferred drug for status epilepticus because it has a slower onset of action compared to diazepam and may not be as effective in quickly stopping prolonged seizures. Phenytoin is more commonly used for long-term seizure control rather than acute seizure management.
Intramuscular phenobarbital (Option C) is not the preferred choice for status epilepticus due to its slower onset of action compared to intravenous diazepam. In an emergency situation like status epilepticus, a faster-acting medication like diazepam is crucial for prompt seizure control.
Rectal paraldehyde (Option D) is not the preferred drug for status epilepticus because it is an older medication with a less predictable absorption rate and slower onset of action compared to intravenous diazepam. In a time-sensitive situation like status epilepticus, a medication with a more reliable and rapid effect, like diazepam, is preferred.
In an educational context, understanding the rationale behind the choice of medication for status epilepticus is crucial for healthcare professionals, especially those working in emergency or critical care settings. Knowing the pharmacological properties and appropriate use of each drug option can help in making quick and effective decisions to manage patients experiencing status epilepticus, ultimately improving patient outcomes and safety.
Intravenous phenytoin sodium (Option B) is not the preferred drug for status epilepticus because it has a slower onset of action compared to diazepam and may not be as effective in quickly stopping prolonged seizures. Phenytoin is more commonly used for long-term seizure control rather than acute seizure management.
Intramuscular phenobarbital (Option C) is not the preferred choice for status epilepticus due to its slower onset of action compared to intravenous diazepam. In an emergency situation like status epilepticus, a faster-acting medication like diazepam is crucial for prompt seizure control.
Rectal paraldehyde (Option D) is not the preferred drug for status epilepticus because it is an older medication with a less predictable absorption rate and slower onset of action compared to intravenous diazepam. In a time-sensitive situation like status epilepticus, a medication with a more reliable and rapid effect, like diazepam, is preferred.
In an educational context, understanding the rationale behind the choice of medication for status epilepticus is crucial for healthcare professionals, especially those working in emergency or critical care settings. Knowing the pharmacological properties and appropriate use of each drug option can help in making quick and effective decisions to manage patients experiencing status epilepticus, ultimately improving patient outcomes and safety.